MENU
ENGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

enGene Holdings (ENGN) Ownership - Who owns enGene Holdings?

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC)... Show more

Profile

Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
667.37M
P/E Ratio
N/A
Total Cash
193.74M
Projected Growth
N/A
Total Debt
31.8M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ENGN
Capitalization
667M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
194M
Total Cash/Share
2.89
Total Debt
31.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
168M
P/B Ratio
3.98
Cash Flow
N/A
Earnings
-2.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
513M
Current Ratio
6.30
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-113.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.05
Shares Held By Institutions
303M
Shares Outstanding - Current
67M
Total Liabilities
53.8M
Total Volume MTD
N/A
Value
1
Gain YTD
10.410
View a ticker or compare two or three
ENGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A